COVID–19 Testing Coverage Act of 2021

Bill: 117-hr-5432
Sponsor: full_name: Rep. Miller-Meeks, Mariannette [R-IA-2]
Introduced: 2021-09-30
Policy area: Health
Subjects: Cardiovascular and respiratory health

Emergency medical services and trauma care

Employee benefits and pensions

Health care costs and insurance

Health care coverage and access

Immunology and vaccination

Infectious and parasitic diseases

Medical tests and diagnostic methods
Latest action: action_date: 2021-10-01
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2021-09-30
action_desc: Introduced in House
text: <p><strong>COVID-19 Testing Coverage Act of 2021</strong><br> <br> This bill requires private health insurance to cover, without cost sharing, testing to assess the T cell immune response of an individual to COVID-19. This test indicates a recent or prior infection with COVID-19.<br> </p>

tv_txt: I 117th CONGRESS 1st Session H. R. 5432 IN THE HOUSE OF REPRESENTATIVES September 30, 2021 Mrs. Miller-Meeks introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committees on Ways and Means , and Education and Labor , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Families First Coronavirus Response Act to require group health plans and health insurance issuers to cover T cell immune response testing without the imposition of cost sharing.

1. Short title This Act may be cited as the COVID–19 Testing Coverage Act of 2021 . 2. Requiring group health plans and health insurance issuers to cover T cell immune response testing without the imposition of cost sharing Section 6001(a) of the Families First Coronavirus Response Act ( 42 U.S.C. 1320b–5 note) is amended— (1) in the matter preceding paragraph (1), by inserting (or, in the case of tests described in paragraph (3), beginning on or after the date of the enactment of such paragraph) after the date of the enactment of this Act ; and (2) by adding at the end the following new paragraph: (3) Tests furnished to assess the T cell immune response of an individual to COVID–19. .